PillRx only · Tablet, Chewable · Oral
Lamotrigine
Lamotrigine
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers6 labelers
Packages40
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.155
Latest avg · Jun 17, 2026
-4%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | unknown | 10 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 10 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 6 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 6 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 6 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.